The AWC was used in 8 patients with GI lesions 17-45 mm (average 35.9 mm)
Ovesco is proud to announce that both the OTSC® System and the remOVE System including
6 consecutive T1-ERC patients underwent FTRD application which resulted in complete endoscopic resection in all
EFTR of duodenal lesions in 20 patients showed technical success in 17/20 (85.0 %), a
96.4 % hemostasis rate is reported from 286 emergency endoscopies for either upper or lower
Case series of 11 OTSC applications in 10 pediatric patients shows 100 % technical success
Italian single-center study of 20 consecutive patients with non-lifting lesions, adenoma recurrence/relapse of previous endoscopic
Ovesco Endoscopy AG merges all business entities in the Americas into its Ovesco Endoscopy USA
OTSC use in patients with refractory gastrointestinal diseases achieved an overall clinical success rate of
In a multicentric cohort of 100 consecutive patients with mean age 72 y, 51 %